Cyclerion Therapeutics (CYCN) EBT Growth (3y) (2021 - 2025)
Cyclerion Therapeutics (CYCN) EBT Growth (3y) (2021 - 2025) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
EBT Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
719,706.53 Bn |
719,706.50 Bn |
- |
- |
| 2 |
Belite Bio |
55,800.00 Bn |
55,800.00 Bn |
- |
84.25% |
| 3 |
Quantum Biopharma |
18,182.30 Bn |
18,182.29 Bn |
- |
32.96% |
| 4 |
Legend Biotech |
3,154.00 Bn |
3,153.71 Bn |
242.10 Mn |
28.95% |
| 5 |
Akari Therapeutics |
1,844.30 Bn |
1,844.29 Bn |
- |
-49.71% |
| 6 |
Evaxion A |
1,567.96 Bn |
1,567.94 Bn |
- |
20.92% |
| 7 |
Psyence Biomedical |
251.43 Bn |
251.42 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
112.56 Bn |
105.31 Bn |
2.59 Bn |
12.01% |
| 9 |
Abivax |
94.37 Bn |
94.37 Bn |
- |
- |
| 10 |
Cyclerion Therapeutics |
11.50 Mn |
8.26 Mn |
- |
- |
| Date | Value |
|---|
| Sep 30, 2025 |
39.39% |
| Jun 30, 2025 |
50.07% |
| Mar 31, 2025 |
51.77% |
| Dec 31, 2024 |
26.72% |
| Sep 30, 2024 |
53.59% |
| Jun 30, 2024 |
55.94% |
| Mar 31, 2024 |
50.57% |
| Dec 31, 2023 |
54.64% |
| Sep 30, 2023 |
34.79% |
| Jun 30, 2023 |
54.30% |
| Mar 31, 2023 |
45.50% |
| Dec 31, 2022 |
44.50% |
| Sep 30, 2022 |
45.11% |
| Jun 30, 2022 |
25.32% |
| Mar 31, 2022 |
29.71% |
| Dec 31, 2021 |
22.58% |
| Sep 30, 2021 |
27.23% |
| Jun 30, 2021 |
18.41% |
| Mar 31, 2021 |
19.08% |
